Delivery Order SPE2DB24D9144-SPE2DB24FCMGX
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,311.35 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order, valued at $8,622.72, is for the supply of 120 capsules of the medication XTANDI 40 MG. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,311.35 contract is for the supply of a pharmaceuticals item, XTANDI 40 MG CAPSULE 120S, with a performance period through September 9, 2024. DMS Pharmaceutical Group is an established federal contractor that holds a large $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $129,645.00 order is for the pharmaceutical product XTANDI 40 MG CAPSULE 120S. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA Troop Support Medical to provide a variety of pharmaceutical and medical supplies, including products such as flumazenil injection, prednisone tablets, and epinephrine...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price Delivery Order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued at up to $4,999,999 through 2025, to provide a broad range of pharmaceutical items to military health facilities worldwide. DMS...
This firm fixed price delivery order was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The $25,868.10 order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, to be delivered by January 8, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a variety of brand name and generic prescription and over-the-counter drug supplies to the Department of Defense. This delivery order is part of a...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $4,321.50 order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, with a completion date of May 11, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 contract is for the delivery of XTANDI 40 MG CAPSULE 120S to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,169.59, is for the delivery of XTANDI 40 MG TABLET 120S. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,868.10 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a prescription medication, and is not associated with any set-aside program. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows...